Full-Time

Director – Medical Safety Science

Confirmed live in the last 24 hours

Revolution Medicines

Revolution Medicines

201-500 employees

Develops precision oncology therapies

Biotechnology

Senior

San Carlos, CA, USA

Required Skills
Data Analysis
Requirements
  • 5 or more years of drug development experience in the pharmaceutical or related industry, with at least 2 years in Safety Science
  • Relevant postgraduate qualification (e.g., MD, PharmD, PhD/MSc in a Life sciences discipline, or other post-graduate health professional qualifications)
  • Proven success in creating and sustaining strong relationships with internal and external business partners
  • Demonstrated ability to lead and influence in a global matrix environment
  • Ability to apply complex data analysis and statistical methods to evaluate scientific data
Responsibilities
  • Safety surveillance and risk management activities including medical review of ICSRs and safety data
  • Contribute to safety surveillance strategy and recommend risk mitigation measures
  • Establish collaborative relationships with key stakeholders for product safety strategy
  • Conduct risk management activities and contribute to regulatory authority submissions
  • Accountable for safety components of study reports and regulatory documents

Revolution Medicines specializes in developing precision oncology therapies, particularly RAS(ON) inhibitors and RAS Companion inhibitors, with their lead product candidate, RMC-4630, currently in a Phase 1/2 clinical program targeting specific oncogenic mutations in various tumor types. The company's main focus is on developing these therapies to target specific oncogenic mutations in different tumor types, utilizing precision oncology technologies.

Company Stage

IPO

Total Funding

$1.3B

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

19%

1 year growth

50%

2 year growth

97%